SCHEMBL14896947

SCHEMBL14896947

Cc1nc2ccc(-c3ccccc3Cl)nn2c1C(=O)Nc1ccc(O)nn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHB3 P54753 2/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TP53 P04637 1/20 0.37
▸ WNT3A P56704 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SCN10A Q9Y5Y9 1/20 0.35
▸ TGFBR1 P36897 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14896803 0.92 EPHB3 (0.41) EPHB3NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14896912 0.89 EPHB3 (0.39) EPHB3NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14897208 0.86 EPHB3 (0.40) EPHB3NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL16265239 0.85 EPHB3 (0.37) EPHB3NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL18654634 0.83 SCN10A (0.42) SCN10AABL1
SCHEMBL16265183 0.82 NPC1 (0.39) EPHB3NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14896966 0.80 ADORA2A (0.42) NPC1RAB9ASMN1; SMN2TP53ALDH1A1
SCHEMBL14897228 0.80 NPC1 (0.40) NPC1RAB9AKMT2ASMN1; SMN2TP53
SCHEMBL14897337 0.80 SORT1 (0.39) EPHB3NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL18654428 0.79 EPHB3 (0.41) EPHB3NPC1RAB9AKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2768509-B1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2017-03-22 — — EP disclosed
WO-2013059587-A9 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2014-10-23 — — WO disclosed
WO-2013059587-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2013-04-25 — — WO disclosed
Send feedback